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Two murine monoclonal antibodies (MAb), 2C5-F10 and 8D1-H10, reactive with Escherichia coli O4 and H5
antigens, respectively, were generated and characterized. Enzyme immunoassays and immunoblots demon-
strated that MAb 2C5-F10 reacted specifically with lipopolysaccharide O antigen of E. coli O4 isolates, while
MAb 8D1-H10 reacted with E. coli strains expressing H5 flagella.
Escherichia coli expressing O4 lipopolysaccharide (LPS)
and/or H5 flagellin frequently causes extraintestinal infections
in humans and domestic animals (1, 10, 19). E. coli O4 organ-
isms are common etiologic agents of human, canine, and feline
genitourinary tract infections, manifested as pyelonephritis,
cystitis, prostatitis, urosepsis, and asymptomatic bacteriuria (4,
8, 13, 25, 31). In particular, the E. coli O4:H5 serotype is a
potent human uropathogen, especially the disseminated viru-
lent J96 clone (14, 15). E. coli O4 and/or H5 antigens are also
associated with enteric disease. Shiga toxin-producing E. coli
(STEC) O4:H-negative (26), O4:H5 (11), O4:H10 (29), O2:H5
(5, 27), and O75:H5 (5) strains have caused hemorrhagic colitis
and hemolytic uremic syndrome cases, while non-STEC O4
and enteroaggregative O4 have caused pediatric diarrhea out-
breaks (6, 7). STEC O4:H-negative (28), O4:H4 (3), O4:H21
(24), O4:H25 (30), and O2:H5 (23) have been isolated from
healthy cattle, while STEC O4 and non-STEC O4 have been
associated with calves (18), pigs (9), and lambs (2) with diar-
rhea. While the E. coli O4 and H5 antigens are both markers
of strain pathogenic potential, the O4 antigen moiety may itself
function as a urovirulence factor (22).
Bacteria reference laboratories usually perform E. coli O
and H serotyping using agglutination assays and rabbit hyper-
immune antisera against reference O (n  181) and H (n  52)
antigens (20; R. A. Wilson, personal communication). How-
ever, absorbed anti-E. coli O4 polyclonal antibodies (PAb) may
cross-react with E. coli possessing O antigens 12, 13, 16, 18, 19,
and 102 (20). Furthermore, E. coli expressing H antigens 1, 4,
8, 12, 38, 44, and 56 may cross-react with anti-H5 PAb (R. A.
Wilson, personal communication). Anti-E. coli O4 and H5
monoclonal antibodies (MAb) have not been reported but
offer potential diagnostic specificity, reagent quality, and typ-
ing assay format flexibility advantages over conventional ag-
glutinating PAb. We generated anti-O4 and anti-H5 MAb in
order to possess accurate serotyping reagents for use in ongo-
ing and planned epidemiologic surveys for pathogenic and
zoonotic E. coli in livestock.
MAb were produced from splenocytes of BALB/c mice im-
munized with E. coli O4:K3:H5 (E. coli Reference Center
[ECRC] U4-41, the O4 and H5 reference strain) (20) whole-
bacterium lysate and boosted with semipurified H5 flagellin
(12). Immunization, hybridoma and ascites production, and
MAb screening, isotyping, and characterization protocols were
as previously described (12, 21). One anti-E. coli O4 MAb
(2C5-F10; immunoglobulin M [IgM] isotype) and one anti-H5
MAb (8D1-H10; IgG1 isotype) were generated and character-
ized. MAb diagnostic sensitivity and specificity were estimated
by enzyme-linked immunosorbent assay (ELISA) reactivity
with whole-bacterium lysate preparations from 350 antigeni-
cally diverse gram-negative bacterial (272 E. coli and 78 non-E.
coli) strains. The E. coli subset consisted of 8 O4:H5 strains, 4
O4:non-H5 strains, 8 non-O4:H5 strains, and 252 non-O4:
non-H5 (including 1 non-O4:H autoagglutinable [HA]) strains
of various O:H serotypes including 12 non-O4 isolates re-
ported to react with anti-O4 PAb (O12 [n  2], O16, O18 [n 
5], O19 [n  3], O102) and 33 non-H5 isolates reported to
react with anti-H5 PAb (H1 [n  5], H4 [n  14], H8 [n  5],
H12 [n  4], H38 [n  3], H44, and H56). Overall, E. coli
isolates possessed 102 different O antigens and 51 different H
antigens. Non-E. coli strains consisted of 50 Salmonella spp.
and 28 other gram-negative bacteria from 22 genera. For
ELISA, bacterial-antigen-coated plates were sequentially incu-
bated with MAb (diluted ascites fluid), horseradish peroxidase
(HRP)-conjugated antibody against mouse IgG plus mouse
IgM (anti-mouse IgGIgM), and 2,2-azino-di-[3-ethylbenz-
thiazoline sulfonate(6)] solution (ABTS peroxidase substrate)
(12). ELISA optical density at dual wavelengths of 405 and 490
nm (OD405/490) was measured, and OD405/490 of 0.200 was
considered positive (12). Dot box plots (16) of MAb ELISA
OD405/490 values for bacterial antigen subsets were generated
(Prism 3.0; Graph Pad Software Inc., San Diego, Calif.), and
MAb diagnostic-sensitivity and -specificity point estimates with
exact binomial 95% confidence intervals (CI) were calculated
(Epi Info 6.0; Centers for Disease Control and Prevention,
Atlanta, Ga.). Sensitivity was defined as the number of MAb
ELISA-positive isolates per the total number of isolates tested
possessing the target (O4 or H5) antigen. Specificity was de-
fined as the number of MAb ELISA-nonreactive isolates per
the total number of isolates tested that did not possess the
target antigen.
MAb 2C5-F10 was ELISA reactive with 12 E. coli O4 iso-
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FIG. 1. Dot box plot of ELISA reactivities of 272 whole-bacterium lysates with anti-E. coli O4 MAb 2C5-F10. ELISA plates coated with
whole-bacterium antigens were incubated sequentially with MAb 2C5-F10 (ascites fluid; 1:32,000), anti-mouse IgGIgM-HRP conjugate, and
ABTS peroxidase substrate. A MAb ELISA OD405/490 of 0.200 was considered positive. Dots represent means of duplicate OD values. The
bottom and top edges of the superimposed box plots are the 25th and 75th distribution percentiles, respectively; the central horizontal line
represents the median (50th percentile), and the central vertical lines extend from the box as far as the data extend (range). CRX, non-E. coli O4
bacteria known to cross-react with anti-E. coli O4 PAb. Data for MAb ELISA reactivity with 78 non-E. coli isolates are not shown.
FIG. 2. Dot box plot of ELISA reactivities of 272 whole-cell bacterium lysates with anti-E. coli H5 MAb 8D1-H10. ELISA plates coated with
whole-bacterium antigens were incubated sequentially with MAb 8D1-H10 (ascites fluid; 1:50,000), IgGIgM-HRP, and ABTS solution. OD
values represent means of duplicate wells. For dot box plot interpretation, see the legend for Fig. 1. CRX, non-E. coli H5 bacteria known to
cross-react with anti-E. coli H5 PAb; *, datum point for E. coli O2:HA (autoagglutinable) 92–0609, which was presumptively H5 based on Western




























lates (sensitivity, 100%; 95% CI, 73.5 to 100) and nonreactive
with 260 non-O4 E. coli and 78 non-E. coli isolates (specificity,
100%; 95% CI, 98.9 to 100) (Fig. 1). Significantly, there was no
MAb ELISA reactivity with 12 bacteria that cross-react with
anti-O4 PAb.
MAb 8D1-H10 reacted with 13 of 16 E. coli H5 isolates
(sensitivity, 81.3%; 95% CI, 54.4 to 96.0) (Fig. 2); the three
nonreactive strains were E. coli O75:H5 isolates. In spite of
repeated attempts to induce and select for motility using fla-
gellum broth and semisolid motility agar (12), these three
strains remained nonmotile in our laboratory both macroscop-
ically in media and microscopically under phase-contrast mi-
croscopy. This suggests that these E. coli O75:H5 strains may
have been nonreactive with the anti-H5 MAb due to lack of
expression of flagellar antigens (12). This MAb did not react
with 78 non-E. coli strains but reacted with 1 of 255 non-H5 E.
coli (specificity, 99.6%; 95% CI, 97.9 to 99.9) strains (Fig. 2).
The cross-reactive strain was E. coli O2:HA (ECRC 94-0609),
which possesses an unknown H-antigen.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) followed by Western immunoblotting using
whole-bacterium lysates, semipurified flagellin, and LPS prep-
arations from E. coli O4 and H5 and non-O4 and non-H5
antigens confirmed MAb O4 and H5 specificity (12, 21) (Fig. 3
and 4). Reactive bands from gels transferred onto polyvinyli-
dene difluoride membranes and incubated with MAb were
revealed with HRP-conjugated rabbit anti-mouse IgGIgM
and diaminobenzidine substrate. The ladder pattern character-
istic of LPS was observed on silver-stained gels and membranes
incubated with anti-O4 MAb 2C5-F10 (Fig. 3), which reacted
only with E. coli O4:H5 (lanes 1 to 3) and O4:H32 (lane 4), but
not with four other whole-bacterium preparations (Fig. 3B).
FIG. 3. SDS-PAGE and Western blots of MAb 2C5-F10 (anti-E.
coli O4) on whole-bacterium antigens (25 g per well). Lane 1, E. coli
O4:H5 U4-41; lane 2, E. coli O4:H5 J96; lane 3, E. coli O4:H5 CA002;
lane 4, O4:H32 90-1870; lane 5, E. coli O-negative:NM CDC 3377-85;
lane 6, O-negative:H-negative 90-1870; lane 7, E. coli O18:H5 94-0061;
lane 8, E. coli O12:H6 H9; and lane 9, E. coli O13:H11 SU 4321-41.
After electrophoresis, one gel was silver stained (A). The other gel was
transferred onto a polyvinylidene difluoride membrane and incubated
with MAb 2C5-F10 (cell culture medium; 1:2) (B). MAb-reactive
bands were revealed with rabbit anti-mouse IgGIgM-HRP (1:1,000)
and diaminobenzidine substrate. Molecular masses (in kilodaltons) are
indicated on the left.
FIG. 4. SDS-PAGE and Western blots of MAb 8D1-H10 (anti-E.
coli H5) on partially purified flagellins (lanes 1 to 3; 2 g per well) and
whole-bacterium antigens (lanes 4 to 9; 24 g per well). Lane 1, E. coli
O157:H7 43895; lane 2, E. coli O9:H12 Bi316-42; lane 3, E. coli O4:H5
U4-41; lane 4, E. coli O4:H5 J96; lane 5, E. coli O75:H5 CL35; lane 6,
E. coli O166:H-negative 94-0287; lane 7, E. coli O139:H56 SN3N/1;
lane 8, E. coli O4:H5 91-1750; and lane 9, E. coli O2:HA 94-0609. After
electrophoresis, one gel was Coomassie brilliant blue stained (A). The
other gel was transferred onto a polyvinylidene difluoride membrane
and incubated with MAb 8D1-H10 (cell culture medium; 1:1,000) (B).
MAb-reactive bands were revealed with rabbit anti-mouse IgGIgM-
HRP (1:1,000) and diaminobenzidine substrate. Molecular masses (in
kilodaltons) are indicated on the left.



























Similar results were obtained using semipurified LPS as anti-
gen (data not shown).
Specificity of MAb 8D1-H10 for H5 antigen was confirmed
by SDS-PAGE of semipurified flagellins and whole-bacterium
preparations followed by immunoblotting (Fig. 4). MAb 8D1-
H10 reacted predominantly with purified flagellins (lane 3) and
whole-bacterium preparations (lanes 4, 5, and 8) of E. coli H5
at the expected molecular mass of 46 kDa (17). MAb 8D1-H10
immunoblotting of ELISA-reactive E. coli O2:HA 94-0609
produced a doublet of reactive bands at Mr of 46 and 37
kDa. The 46-kDa reactive band of this autoagglutinable strain
was of a size consistent with H5 flagellin; the 37-kDa band
could be an H5 degradation product or a non-H5 flagellin.
To validate MAb performance, a second panel of 37 E. coli
O4, H5, non-O4, and non-H5 human clinical isolates (kindly
provided by J. R. Johnson, University of Minnesota, St. Paul)
was tested blindly for ELISA reactivity separately with each
MAb (Table 1). The anti-O4 MAb reacted with 11 of 12 E. coli
O4 strains and with 0 of 25 non-O4 strains. The nonreactive E.
coli O4:H-multiple strain Z was serotyped as O82:H-multiple
when submitted to the ECRC after MAb ELISA testing. The
anti-H5 MAb reacted only with the four E. coli H5 strains.
In conclusion, we produced MAb against the E. coli O4 and
H5 antigens that appeared to be sensitive and specific as as-
sessed by ELISA and immunoblotting. These MAb have po-
tential clinical use as immunodiagnostic or serotyping reagents,
especially if used in combination with other phenotypic or
genotypic pathogenicity markers. They may be of particular
utility for experimental or epidemiologic studies of extraintes-
tinal E. coli O4:H5 infections.
We thank R. A. Wilson, ECRC, Pennsylvania State University, Uni-
versity Park, and J. R. Johnson, University of Minnesota, St. Paul, for
providing bacterial strains. We also acknowledge S. Fryda-Bradley, R.
Mlejnek, and S. Yang for technical assistance and J. Rosch for manu-
script preparation.
REFERENCES
1. Blanco, J. E., J. Blanco, M. Blanco, M. P. Alonso, and W. H. Jansen. 1994.
Serotypes of CNF1-producing Escherichia coli strains that cause extraintes-
tinal infections in humans. Eur. J. Epidemiol. 10:707–711.
2. Blanco, J., D. Cid, J. E. Blanco, M. Blanco, J. A. Ruiz Santa Quiteira, and
R. de la Fuente. 1996. Serogroups, toxins and antibiotic resistance of Esch-
erichia coli strains isolated from diarrhoeic lambs in Spain. Vet. Microbiol.
49:209–217.
3. Blanco, M., J. Blanco, J. E. Blanco, E. A. Gonzalez, T. A. Gomes, L. F.
Zerbini, T. Yano, and A. F. de Castro. 1994. Genes coding for Shiga-like
toxins in bovine verotoxin-producing Escherichia coli (VTEC) strains belong-
ing to different O:K:H serotypes. Vet. Microbiol. 42:105–110.
4. Blanco, M., J. E. Blanco, M. P. Alonso, and J. Blanco. 1996. Virulence
factors and O groups of Escherichia coli isolates from patients with acute
pyelonephritis, cystitis and asymptomatic bacteriuria. Eur. J. Epidemiol.
12:191–198.
5. Bockemuhl, J., S. Aleksic, and H. Karch. 1992. Serological and biochemical
properties of shiga-like toxin (verocytotoxin)-producing strains of Esche-
richia coli, other than O-group 157, from patients in Germany. Zentbl.
Bakteriol. 276:189–195.
6. Cobeljic, M., B. Miljkovic-Selimovic, D. Paunovic-Todosijevic, Z. Velickovic,
Z. Lepsanovic, N. Zec, D. Savic, R. Ilic, S. Konstantinovic, B. Jovanovic, and
V. Kostic. 1996. Enteroaggregative Escherichia coli associated with an out-
break of diarrhoea in a neonatal nursery ward. Epidemiol. Infect. 117:11–16.
7. Colonna, B., L. Ranucci, P. A. Fradiani, M. Casalino, A. Calconi, and M.
Nicoletti. 1992. Organization of aerobactin, hemolysin, and antibacterial
resistance genes in lactose-negative Escherichia coli strains of serotype O4
isolated from children with diarrhea. Infect. Immun. 60:5224–5233.
8. Donneberg, M. S., and R. A. Welch. 1996. Virulence determinants of uro-
pathogenic Escherichia coli, p. 135–174. In H. L. T. Mobley and J. W. Warren
(ed.), Urinary tract infections: molecular pathogenesis and clinical manage-
ment. American Society for Microbiology, Washington D.C.
9. Garabal, J. I., E. A. Gonzalez, F. Vazquez, J. Blanco, M. Blanco, and J. E.
Blanco. 1996. Serogroups of Escherichia coli isolated from piglets in Spain.
Vet. Microbiol. 48:113–123.
10. Gransden, W. R., S. J. Eykyn, L. Phillips, and B. Rowe. 1991. Bacteremia due
to Escherichia coli: a study of 861 episodes. Rev. Infect. Dis. 12:1008–1018.
11. Gunzburg, S., M. Gracey, D. Forbes, L. Hewitt, and K. Bettelheim. 1988.
Haemolytic-uraemic syndrome and verocytotoxigenic Esch. coli. Med. J.
Aust. 149:54–55.
12. He, Y., J. E. Keen, R. B. Westerman, E. T. Littledike, and J. Kwang. 1996.
Monoclonal antibodies for detection of the H7 antigen of Escherichia coli.
Appl. Environ. Microbiol. 62:3325–3332.
13. Johnson, J. R. 1991. Virulence factors in Escherichia coli urinary tract infec-
tion. Clin. Microbiol. Rev. 4:80–128.
14. Johnson, J. R., T. A. Russo, F. Scheutz, J. J. Brown, L. Zhang, K. Palin, C.
Rode, C. Bloch, C. F. Marrs, and B. Foxman. 1997. Discovery of dissemi-
nated J96-like strains of uropathogenic Escherichia coli O4:H5 containing
genes for both PapGJ96 (class I) and PrsGJ96 (class III) Gal(1-4) Gal-
binding adhesin. J. Infect. Dis. 175:983–988.
15. Johnson, J. R., A. E. Stapleton, T. A. Russo, F. Scheutz, J. J. Brown, and J. N.
Maslow. 1997. Characteristics and prevalence within serogroup O4 of a
J96-like clonal group of uropathogenic Escherichia coli O4:H5 containing the
class I and class III alleles of papG. Infect. Immun. 65:2153–2159.
16. Krieg, A. F., J. R. Beck, and M. B. Bongiovanni. 1988. The dot plot: a starting
TABLE 1. ELISA reactivities of MAb 2C5-F12 (anti-O4) and 8D1-
H10 (anti-H5) to 37 E. coli whole-bacterium antigens








O4:non-H5 O4:NM Bos 021  
O4:NM Bos 038  
O4:NM Bos 046  
O4:NM Bos 105  
O4:NM PM8  
O4:H1 Afr 015  
O4:H1 Bos 040  
O4:H1 V31  
O4:H-multiplea Z  
O4:H5 O4:H5 CP9  
O4:H5 R28  
O4:H5 518  
non-O4:H5 O85/157:H5 Bos 023  
non-O4:non-H5 Ox7w:H16 Y  
O15:H1 2H17  
O15/40:H1 V32  
O17:H8 V11  
O18ac:H7 2H25  
O18:Haggeb V  
O18:H23 C  
O19:H27 G  
O36:ntc U  
O59:nt B  
O63w:H6 R  
O64:H21 PM1  
O73w:nt F  
O75:NM N  
O82:H12 X  
O84:H- V12  
O86:H12 M  
O113:H- E  
O143:H- 2V5  
O149w:H8 I  
O152:Hnt IA  
O169w:H8 L  
Ont:H7/24 D  
Ont:H16 A  
a Serotyped as O82:H-multiple on resubmission to ECRC after MAb testing.
b agge, autoaggregative.
c nt, nontypeable.



























point for evaluating test performance. JAMA 260:3309–3312.
17. Lawn, A. M. 1977. Comparison of the flagellins from different morphotypes
of Escherichia coli. J. Gen. Microbiol. 101:121–131.
18. Orden, J. A., J. A. Ruiz-Santa-Quiteria, D. Cid, S. Garcia, R. Sanz, and R.
de la Fuente. 1998. Verotoxin-producing Escherichia coli (VTEC) and eae-
positive non-VTEC in 1-30-days-old diarrhoeic dairy calves. Vet. Microbiol.
63:239–248.
19. Ørskov, F., and I. Ørskov. 1992. Escherichia coli serotyping and disease in
man and animals. Can. J. Microbiol. 38:699–704.
20. Ørskov, F., and I. Ørskov. 1984. Serotyping of Escherichia coli. Methods
Microbiol. 14:43–112.
21. Rivera-Betancourt, M., and J. E. Keen. 2000. Murine monoclonal antibodies
specific for Escherichia coli O26 and O111. Appl. Environ. Microbiol. 66:
4124–4127.
22. Russo, T. A., J. J. Brown, S. T. Jodush, and J. R. Johnson. 1996. The O4
specific antigen moiety of lipopolysaccharide but not the K54 group 2 cap-
sule is important for urovirulence of an extraintestinal isolate of Escherichia
coli. Infect. Immun. 64:2343–2348.
23. Sandhu, K. S., R. C. Clarke, K. McFadden, A. Brouwer, M. Louie, J. Wilson,
H. Lior, and C. L. Gyles. 1996. Prevalence of the eaeA gene in verotoxigenic
Escherichia coli strains from dairy cattle in Southwest Ontario. Epidemiol.
Infect. 116:1–7.
24. Suthienkul, O., J. Edward Brown, J. Seriwatana, S. Tienthongdee, S. Sas-
travaha, and P. Echeverria. 1990. Shiga-like-toxin-producing Escherichia coli
in retail meats and cattle in Thailand. Appl. Environ. Microbiol. 56:1135–
1139.
25. Terai, A., S. Yamamoto, K. Mitsumori, Y. Okada, H. Kurazono, Y. Takeda,
and O. Yoshida. 1997. Escherichia coli virulence factors and serotypes in
acute bacterial prostatitis. Int. J. Urol. 4:289–294.
26. Tzipori, S., K. I. Wachsmuth, J. Smithers, and C. Jackson. 1988. Studies in
gnotobiotic piglets on non-O157:H7 Escherichia coli serotypes isolated from
patients with hemorrhagic colitis. Gastroenterology 94:590–597.
27. von Wulffen, H., H. Russmann, H. Karch, T. Meyer, M. Bitzan, T. C. Kohrt,
and S. Aleksic. 1989. Verocytotoxin-producing Escherichia coli O2:H5 iso-
lated from patients with ulcerative colitis. Lancet i:1449–1450.
28. Wieler, L. H., E. Vieler, C. Erpenstein, T. Schlapp, H. Steinrück, R. Bauer-
feind, A. Byomi, and G. Baljer. 1996. Shiga toxin-producing Escherichia coli
strains from bovines: association of adhesion with carriage of eae and other
genes. J. Clin. Microbiol. 34:2980–2984.
29. Willshaw, G. A., S. M. Scotland, H. R. Smith, and B. Rowe. 1992. Properties
of vero cytotoxin-producing Escherichia coli of human origin of O serogroups
other than O157. J. Infect. Dis. 166:797–802.
30. Wilson, J. B., R. C. Clarke, S. A. Renwick, K. Bahn, R. P. Johnson, M. A.
Karmali, H. Lior, D. Alves, C. L. Gyles, K. S. Sandhu, S. A. McEwen, and
J. S. Spika. 1996. Vero cytotoxigenic Escherichia coli infection in dairy farm
families. J. Infect. Dis. 174:1021–1027.
31. Yuri, K., K. Nakata, H. Katae, T. Tsukamoto, and A. Hasegawa. 1999.
Serotypes and virulence factors of Escherichia coli strains isolated from dogs
and cats. J. Vet. Med. 61:37–40.



















ugust 31, 2007 
jcm
.asm
.org
D
ow
nloaded from
 
